Table 3—

Comparison between the intervention and reference group: patient outcomes

Study groupBaselineAfter 18 monthsAfter 30 monthsAfter 42 monthsOR (95% CI)∗
nIG312290242197
RG77735634
HbA1c <7.0%IG41.053.042.344.71.08
RG45.843.350.035.7(0.51–2.29)
HbA1c ≤8.5%IG67.879.682.583.01.18
RG72.275.088.178.6(0.61–2.28)
Systolic BP ≤140 mmHgIG31.038.231.143.40.99
RG31.131.454.547.8(0.60–1.64)
Systolic BP ≤160 mmHgIG69.075.670.478.01.25
RG63.564.379.582.6(0.73–2.12)
Diastolic BP ≤90 mmHgIG79.780.977.283.60.73
RG59.570.088.691.3(0.39–1.37)
Diastolic BP ≤95 mmHgIG86.186.686.492.50.44
RG68.990.093.291.3(0.20–0.97)
TC <5.2 mmol/lIG21.024.730.027.91.06
RG22.223.026.233.3(0.55–2.05)
TC <6.5 mmol/lIG68.368.870.072.10.96
RG77.872.183.366.7(0.47–1.94)
HDL cholesterol >1.1 mmol/lIG44.147.548.354.20.90
RG47.241.752.461.9(0.47–1.74)
HDL cholesterol ≥0.9 mmol/lIG85.087.877.288.21.58
RG83.376.773.885.7(0.74–3.35)
Triglycerides <1.7 mmol/lIG46.148.250.544.80.76
RG47.950.052.452.4(0.39–1.49)
Triglycerides <2.2 mmol/lIG69.066.570.173.81.12
RG74.670.069.057.1(0.57–2.21)
BMI <25 kg/m2IG32.132.418.624.20.83
RG29.924.334.131.8(0.39–1.74)
BMI ≤ 27 kg/m2IG52.653.445.743.61.28
RG55.848.647.754.5(0.50–3.26)
  • Data are n unless otherwise indicated.

  • *

    * Adjusted for sex, age, duration of diabetes, region, treatment, and baseline value.